Healthcare Stocks Rise as Investors Rotate Away From Tech
AbbVie, Eli Lilly, and J&J shares neared all-time highs Friday as investors pivoted to pharma amid tech uncertainty.
Healthcare stocks surged Friday as investors fled technology names in favor of the perceived stability of major pharmaceutical companies, with shares of AbbVie, Eli Lilly, and Johnson & Johnson all on pace to set all-time highs by the close of trading.
The simultaneous record-chasing across three of the sector's biggest names signals a broad-based revival of investor confidence in biopharmaceuticals — a group that has at times struggled to keep pace with the explosive gains logged by mega-cap tech over recent years.
Read more Tech Stocks Slide While Broader Market Holds Steady →
The rotation into healthcare reflects a classic defensive playbook: when uncertainty clouds growth-oriented sectors like technology, institutional and retail investors alike tend to seek shelter in companies with steadier revenue streams, such as drug makers with established product pipelines and recurring demand.
Friday's moves suggest the appetite for biopharmaceutical exposure is not isolated to one company or one drug category, but rather a sector-wide reassessment of where value and safety coexist in a volatile market environment. Whether the momentum holds will likely depend on upcoming earnings reports and any policy developments affecting drug pricing.
Continue reading at MarketWatch.com
